Hematron-AF

Manufacturer
Seyer Pharmatec, Inc.
Effective date
2024-08-13
Label type
DIETARY SUPPLEMENT
Version
1
Source
full-release
Hydrated at
2026-06-01 02:51:07

Label at a glance#

ProductHematron-AF
Active ingredientASCORBIC ACID, .ALPHA.-TOCOPHEROL ACETATE, DL-, LEVOMEFOLATE CALCIUM, CYANOCOBALAMIN, BIOTIN, IRON, CUPRIC SULFATE
Label structure7 sections

Dosage and administration

One caplet daily with or without food or as prescribed by your healthcare provider.

Label contents#

Full prescribing information#

STATEMENT OF IDENTITY SECTION

 Supplement Facts
 Serving Size: 1 Tablet
Amount% Daily
Per ServingValue 
 Vitamin C (as Ascorbic Acid)500 mg 556% 
 Vitamin E (as dl-Alpha Tocopheryl Acetate)13.5 mg 90% 
 Folate (as L-5-methyltetrahydrofolate Calcium)1,020 mcg DFE 255% 
(600 mcg L-5-MTHF) 
 Vitamin B12 (as Cyanocobalamin)60 mcg 2,500%
 Biotin150 mcg 500% 
 Iron (as Carbonyl Iron)150 mg 833% 
 Copper (as Cupric Sulfate)3 mg 333% 
 *Daily Value not established.

OTHER INGREDIENTS:
Microcrystalline Cellulose, Citric Acid, Stearic Acid, Dicalcium Phosphate, Croscarmellose Sodium, Polyvinylpyrrolidone, Hypromellose, Magnesium Stearate, Silicon Dioxide, Starch, Glucose, Calcium Carbonate, Crospovidone, Isomalt, Sodium Lauryl Sulfate, Maltodextrin, Triglycerides, Sucrose, Soy Polysaccharide, Glycerin, Mineral Oil, Polyethylene Glycol, Artificial French Vanilla Flavor, Annatto Extract (color), Propylene Glycol, Tricalcium Phosphate, Potassium Hydroxide, and Talc. Contains: Soy

Contains a bioengineered food ingredient.

HEMATRON AF is a multi-vitamin / multi-mineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency†

†This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

WARNINGS SECTION

WARNING Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

DO NOT USE with individuals with a known hypersensitivity to any of the ingredients. Patients with hemochromatosis and hemosiderosis are contra-indications to iron therapy. This product is not for use in children under 12 years of age.

CAUTION:

PRECAUTIONS SECTION

This product contains 1,020mcg DFE (600mcg L5-MTHF); the maximum safe Reference Daily Intake (RDI) amount for this nutrient is 1000mcg. Folic Acid in doses above 0.1 mg (1000mcg) daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive. There is a potential danger in administering folic acid to patients with undiagnosed anemia since folic acid may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia.

ADVERSE REACTIONS

Allergic sensitization has been reported following both oral and parenteral administration of Folic Acid.

DIRECTIONS FOR USE

DOSAGE & ADMINISTRATION SECTION

One caplet daily with or without food or as prescribed by your healthcare provider.

STORAGE

SAFE HANDLING WARNING SECTION

Store at room temperature, USP.

To report a serious adverse event or to obtain product information, contact (888) 444-5072.

Manufactured in the USA for:
Seyer Pharmatec, Inc.
Caguas, Puerto Rico 00726

DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

HEALTH CLAIM SECTION

Dietary Supplement

EZY-DOSE TABLETS

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

HemaAF-2HemaAF-2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ASCORBIC ACID Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
CYANOCOBALAMIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
LEVOMEFOLIC ACID Pharmacologic Class Indexing1Indexing - Pharmacologic Class20230428

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b82b4008-22fd-05f5-6cc6-c0a6e81c65b8Product name220240805
910c1bd7-67d1-44c7-ad4f-9445f827edccProduct name120230808
cb89b86a-369e-4204-8910-ae797c503af3Product name120230706
0306390c-dd77-4363-afe0-63c58088b2a1Product name120220120
503ea967-4b9c-48cf-9e87-c7975295849dProduct name220220120
d4880ace-a516-8c47-8dfd-73a4ba5887d7Product name220180830
ddff2484-d547-4e6a-bacd-95eef7e31c64Product name220180807
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
90854981-3820-4bc4-a1d3-666ec508941cProduct name220180214
c5cd4727-ac49-4409-82b1-5bd8006c3ec7Product name120171122
d206bb34-ea65-399d-70d9-834f22dc2c18Product name320170724
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11026-2761-9Hematron-AF90 in 1 BOTTLETABLET901

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11026-2761HEMATRON-AF (ASCORBIC ACID, DL-ALPHA TOCOPHERYL ACETATE, L-5-METHYLTETRAHYDROFOLATE CALCIUM, CYANOCOBALAMIN, BIOTIN, CARBONYL IRON, CUPRIC SULFATE) TABLET [SEYER PHARMATEC, INC.]11 package rows20240820_aca66c3e-32b9-4962-a6a0-58245fbbf242.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 39 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11026-276111026-2761-9

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 34 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ascorbic acidASCORBIC ACIDZydus Pharmaceuticals USA Inc.f0b683f8-189b-4a3f-9ffe-f91df6d798b62026-09-03Warnings, Adverse reactionsName fallback
generic name: ASCORBIC ACID
Ascorbic acidASCORBIC ACIDZydus Lifesciences Limitedd2d29ffd-5483-45bb-9d1b-da7af23b37202026-09-03Name fallback
generic name: ASCORBIC ACID
Ascorbic AcidASCORBIC ACIDRenova Pharmaceuticals LLCa6481bae-2397-44c7-a51d-4f47ad91bd2c2026-08-19Warnings, Adverse reactionsName fallback
generic name: ASCORBIC ACID
AscorASCORBIC ACIDMcGuff Pharmaceuticals, Inc.388aad52-fc01-4784-9791-1dbc80c693062026-05-29Warnings, Adverse reactionsName fallback
generic name: ASCORBIC ACID
Ascorbic AcidASCORBIC ACIDFresenius Kabi USA, LLC1606e29f-0e80-4069-b688-daab9cbff20a2025-12-17Warnings, Adverse reactionsName fallback
generic name: ASCORBIC ACID
Skin Renewing SerumASCORBIC ACIDGuangzhou Danting Bath&Body Care Industry Co. Ltd396c2a8d-ac95-cbef-e063-6294a90aff392025-08-23WarningsName fallback
generic name: ASCORBIC ACID

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.